These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2091380

  • 1. [The effect of treatment on the survival rate in chronic glomerulonephritis].
    Belovezhdov N, Robeva R, Dimitrova V.
    Vutr Boles; 1990; 29(6):29-35. PubMed ID: 2091380
    [Abstract] [Full Text] [Related]

  • 2. What is new in therapy of glomerulonephritis in 2003/2004.
    Hruby Z.
    Rocz Akad Med Bialymst; 2004; 49():166-9. PubMed ID: 15631335
    [Abstract] [Full Text] [Related]

  • 3. [The survival of patients with mesangial immunoglobulin A glomerulonephritis].
    Belovezhdov N, Robeva R, Dimitrova V.
    Vutr Boles; 1990; 29(4):40-7. PubMed ID: 2281658
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of extracapillary proliferative glomerulonephritis].
    Cameron JS.
    Dtsch Med Wochenschr; 1988 Nov 18; 113(46):1812-20. PubMed ID: 3056685
    [No Abstract] [Full Text] [Related]

  • 5. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
    Ozdamar SO, Gucer S, Tinaztepe K.
    Pediatr Nephrol; 2003 Jan 18; 18(1):23-8. PubMed ID: 12488986
    [Abstract] [Full Text] [Related]

  • 6. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM, Tareeva IE, Ivanov AA, Troepol'skaia OV, Krasnova TN, Varshavskiĭ VA, Proskurneva EP, Ivanova LV, Khudova IIu, Miroshnichenko NG.
    Ter Arkh; 2002 Jan 18; 74(6):11-8. PubMed ID: 12136475
    [Abstract] [Full Text] [Related]

  • 7. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature.
    D'Amico G.
    Am J Kidney Dis; 1992 Oct 18; 20(4):315-23. PubMed ID: 1415198
    [Abstract] [Full Text] [Related]

  • 8. IgA-dominant glomerulonephritis with a membranoproliferative pattern of injury.
    Andeen NK, Jefferson JA, Akilesh S, Alpers CE, Bissonnette ML, Finn LS, Higgins J, Houghton DC, Kambham N, Magil A, Najafian B, Nicosia RF, Troxell ML, Smith KD.
    Hum Pathol; 2018 Nov 18; 81():272-280. PubMed ID: 30420049
    [Abstract] [Full Text] [Related]

  • 9. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
    Riabov SI, Stavskaia VV, Sheveleva LA.
    Ter Arkh; 1990 Nov 18; 62(9):91-7. PubMed ID: 2281418
    [Abstract] [Full Text] [Related]

  • 10. What do we know about lupus membranous nephropathy? An analytic review.
    Kolasinski SL, Chung JB, Albert DA.
    Arthritis Rheum; 2002 Aug 18; 47(4):450-5. PubMed ID: 12209494
    [No Abstract] [Full Text] [Related]

  • 11. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients.
    Schena FP.
    J Nephrol; 1999 Aug 18; 12 Suppl 2():S125-30. PubMed ID: 10688412
    [Abstract] [Full Text] [Related]

  • 12. [IgA and IgG antibodies to Chlamydia in IgA nephropathy as well as in mesangiocapillary and membranous glomerulonephritis].
    Nagy J, Sarov I, Sámik J, Trinn C, Kun L, Burger T, Sarov B.
    Orv Hetil; 1989 Jul 16; 130(29):1527-30. PubMed ID: 2671859
    [Abstract] [Full Text] [Related]

  • 13. [The late results of treating membranous glomerulonephritis].
    Belovezhdov N, Robeva R, Dimitrova V.
    Vutr Boles; 1990 Jul 16; 29(3):53-60. PubMed ID: 2284800
    [Abstract] [Full Text] [Related]

  • 14. The impact of sex in primary glomerulonephritis.
    Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S, Genes, Gender and Glomerulonephritis Group.
    Nephrol Dial Transplant; 2008 Jul 16; 23(7):2247-53. PubMed ID: 18182409
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of chronic glomerulonephritis with high doses of intravenous immunoglobulin].
    Belovezhdov N, Monova D, Altŭnkova I, Robeva R.
    Vutr Boles; 1990 Jul 16; 29(1):59-68. PubMed ID: 2396419
    [Abstract] [Full Text] [Related]

  • 16. Recovery of Kidney Function Among Patients With Glomerular Disease Starting Maintenance Dialysis.
    Kwong YD, Liu KD, Hsu RK, Johansen KL, McCulloch CE, Seth D, Fallahzadeh MK, Grimes BA, Ku E.
    Am J Kidney Dis; 2021 Feb 16; 77(2):303-305. PubMed ID: 32771649
    [No Abstract] [Full Text] [Related]

  • 17. [The prognosis of the accelerated progression of chronic glomerulonephritis].
    Ratner MIa, Serov VV, Varshavskiĭ VA, Stenina II, Slutskin IM.
    Ter Arkh; 1992 Feb 16; 64(3):116-9. PubMed ID: 1440256
    [Abstract] [Full Text] [Related]

  • 18. Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience.
    Chang JH, Kim DK, Kim HW, Park SY, Yoo TH, Kim BS, Kang SW, Choi KH, Han DS, Jeong HJ, Lee HY.
    Nephrol Dial Transplant; 2009 Aug 16; 24(8):2406-10. PubMed ID: 19264742
    [Abstract] [Full Text] [Related]

  • 19. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O, Watier L, Rossert J, Stengel B, GN-Progress Study Group.
    QJM; 2008 Mar 16; 101(3):215-24. PubMed ID: 18245806
    [Abstract] [Full Text] [Related]

  • 20. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
    Fornasieri A, Perugini C, Seccia M, Napodano P, D'Amico G, Bellomo G.
    J Nephrol; 2002 Mar 16; 15(4):349-57. PubMed ID: 12243363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.